Sendero Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
3,160
+371
+13% +$138K 0.12% 111
2026
Q1
$816K Buy
2,789
+995
+55% +$327K 0.09% 123
2025
Q4
$629K Sell
1,794
-6
-0.3% -$2.03K 0.07% 142
2025
Q3
$582K Sell
1,800
-42
-2% -$13.1K 0.07% 136
2025
Q2
$716K Buy
1,842
+61
+3% +$24.5K 0.09% 127
2025
Q1
$775K Buy
1,781
+7
+0.4% +$2.81K 0.11% 112
2024
Q4
$654K Hold
1,774
0.1% 113
2024
Q3
$922K Hold
1,774
0.15% 84
2024
Q2
$961K Hold
1,774
0.16% 79
2024
Q1
$920K Sell
1,774
-694
-28% -$345K 0.16% 86
2023
Q4
$1.16M Buy
2,468
+492
+25% +$228K 0.22% 72
2023
Q3
$860K Buy
1,976
+1,053
+114% +$478K 0.18% 78
2023
Q2
$410K Buy
923
+57
+7% +$26.3K 0.09% 121
2023
Q1
$398K Buy
866
+110
+15% +$52.3K 0.12% 78
2022
Q4
$388K Sell
756
-143
-16% -$72.6K 0.14% 77
2022
Q3
$408K Buy
899
+198
+28% +$94.7K 0.17% 70
2022
Q2
$338K Buy
701
+74
+12% +$36.6K 0.32% 70
2022
Q1
$308K Sell
627
-226
-26% -$103K 0.14% 75
2021
Q4
$395K Buy
+853
New +$359K 0.18% 66

Other funds holding ELV

Sendero Wealth Management's ELV Position: Q2 2026 in Review

Sendero Wealth Management increased its Elevance Health (ELV) stake by 13% in Q2 2026, buying an estimated $138K and bringing the position to 3,160 shares worth $1.22M. The position accounts for 0.12% of the portfolio, ranked #111.

Sendero Wealth Management first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Sendero Wealth Management held 3,160 shares of Elevance Health worth $1.22M as of Q2 2026.
  • Sendero Wealth Management bought 371 Elevance Health shares in Q2 2026, an estimated $138K.
  • Elevance Health made up 0.12% of Sendero Wealth Management's portfolio in Q2 2026, its #111 holding.
  • Sendero Wealth Management first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sendero Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.